STACY MOTYKIEWICZ: Open Payments
NPI 1952094161 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 78 payments from 15 companies in 2025. Trend: 2023 $347 · 2024 $1,478 · 2025 $1,688
Food & beverage: $1,688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $578 |
| Phathom Pharmaceuticals, Inc. | 5 | $172 |
| Gilead Sciences, Inc. | 2 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $136 |
| Madrigal Pharmaceuticals | 1 | $118 |
| Janssen Biotech, Inc. | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Ipsen Biopharmaceuticals, Inc | 3 | $81 |
| Amgen Inc. | 4 | $68 |
| Ardelyx, Inc. | 4 | $62 |
Products named: RINVOQ, VOQUEZNA, CREON, Epclusa, REZDIFFRA, MAVYRET, TREMFYA, DUPIXENT.
Industry payments across AL — which companies pay providers there.
